79 related articles for article (PubMed ID: 17572007)
21. E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death.
Parish JL; Kowalczyk A; Chen HT; Roeder GE; Sessions R; Buckle M; Gaston K
J Virol; 2006 May; 80(9):4580-90. PubMed ID: 16611918
[TBL] [Abstract][Full Text] [Related]
22. The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins.
Stubenrauch F; Straub E; Fertey J; Iftner T
Int J Cancer; 2007 Nov; 121(10):2284-92. PubMed ID: 17583574
[TBL] [Abstract][Full Text] [Related]
23. [Relationship between nitric oxide in cervical microenvironment and different HPV types and effect on cervical cancer cells].
Wei XM; Wang Q; Gao SJ; Sui L
Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):260-5. PubMed ID: 21609578
[TBL] [Abstract][Full Text] [Related]
24. Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein.
Demeret C; Garcia-Carranca A; Thierry F
Oncogene; 2003 Jan; 22(2):168-75. PubMed ID: 12527886
[TBL] [Abstract][Full Text] [Related]
25. Development of a topical protein therapeutic for human papillomavirus and associated cancers.
Green KL; Gaston K
BioDrugs; 2006; 20(4):209-18. PubMed ID: 16831020
[TBL] [Abstract][Full Text] [Related]
26. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
27. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.
Yamato K; Fen J; Kobuchi H; Nasu Y; Yamada T; Nishihara T; Ikeda Y; Kizaki M; Yoshinouchi M
Cancer Gene Ther; 2006 Mar; 13(3):234-41. PubMed ID: 16138119
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus E2 protein associates with nuclear receptors to stimulate nuclear receptor- and E2-dependent transcriptional activations in human cervical carcinoma cells.
Wu MH; Chan JY; Liu PY; Liu ST; Huang SM
Int J Biochem Cell Biol; 2007; 39(2):413-25. PubMed ID: 17092759
[TBL] [Abstract][Full Text] [Related]
29. [Expression and functional analysis of CRT-E2-EGFP fusion protein in B16 cells].
Yang JL; Liu CB; Li DL; Han L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Oct; 25(10):897-9. PubMed ID: 19811736
[TBL] [Abstract][Full Text] [Related]
30. Exploitation of the Herpes simplex virus translocating protein VP22 to carry influenza virus proteins into cells for studies of apoptosis: direct confirmation that neuraminidase induces apoptosis and indications that other proteins may have a role.
Morris SJ; Smith H; Sweet C
Arch Virol; 2002 May; 147(5):961-79. PubMed ID: 12021867
[TBL] [Abstract][Full Text] [Related]
31. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
32. Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis.
Butz K; Geisen C; Ullmann A; Spitkovsky D; Hoppe-Seyler F
Int J Cancer; 1996 Nov; 68(4):506-13. PubMed ID: 8945623
[TBL] [Abstract][Full Text] [Related]
33. Productive replication of adeno-associated virus can occur in human papillomavirus type 16 (HPV-16) episome-containing keratinocytes and is augmented by the HPV-16 E2 protein.
Ogston P; Raj K; Beard P
J Virol; 2000 Apr; 74(8):3494-504. PubMed ID: 10729123
[TBL] [Abstract][Full Text] [Related]
34. Re-expression of HPV16 E2 in SiHa (human cervical cancer) cells potentiates NF-κB activation induced by TNF-α concurrently increasing senescence and survival.
Prabhavathy D; Subramanian CK; Karunagaran D
Biosci Rep; 2015 Feb; 35(1):. PubMed ID: 25572145
[TBL] [Abstract][Full Text] [Related]
35. Oncolytic adenovirus expressing a p53 variant resistant to degradation by HPV E6 protein exhibits potent and selective replication in cervical cancer.
Heideman DA; Steenbergen RD; van der Torre J; Scheffner M; Alemany R; Gerritsen WR; Meijer CJ; Snijders PJ; van Beusechem VW
Mol Ther; 2005 Dec; 12(6):1083-90. PubMed ID: 16085463
[TBL] [Abstract][Full Text] [Related]
36. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation.
Thomas M; Matlashewski G; Pim D; Banks L
Oncogene; 1996 Jul; 13(2):265-73. PubMed ID: 8710365
[TBL] [Abstract][Full Text] [Related]
37. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
38. DNA replication specificity and functional E2 interaction of the E1 proteins of human papillomavirus types 1a and 18 are determined by their carboxyl-terminal halves.
Gopalakrishnan V; Sheahan L; Khan SA
Virology; 1999 Apr; 256(2):330-9. PubMed ID: 10191198
[TBL] [Abstract][Full Text] [Related]
39. Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins.
Webster K; Taylor A; Gaston K
J Gen Virol; 2001 Jan; 82(Pt 1):201-213. PubMed ID: 11125173
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations.
Wen X; Li D; Zhang Y; Liu S; Ghali L; Iles RK
Anticancer Drugs; 2012 Mar; 23(3):280-7. PubMed ID: 22245994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
